These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17049817)

  • 21. [VISA and hetero-VISA among Staphylococcus aureus strains isolated from clinical cases].
    Młynarczyk G; Młynarczyk A; Łuczak M
    Med Dosw Mikrobiol; 2002; 54(1):9-20. PubMed ID: 12185689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro activity of omiganan pentahydrochloride tested against vancomycin-tolerant, -intermediate, and -resistant Staphylococcus aureus.
    Fritsche TR; Rhomberg PR; Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2008 Apr; 60(4):399-403. PubMed ID: 18178361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of reduced vancomycin susceptibility in methicillin-susceptible Staphylococcus aureus.
    Pillai SK; Wennersten C; Venkataraman L; Eliopoulos GM; Moellering RC; Karchmer AW
    Clin Infect Dis; 2009 Oct; 49(8):1169-74. PubMed ID: 19769538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation of vancomycin and daptomycin susceptibility in Staphylococcus aureus in reference to accessory gene regulator (agr) polymorphism and function.
    Rose WE; Rybak MJ; Tsuji BT; Kaatz GW; Sakoulas G
    J Antimicrob Chemother; 2007 Jun; 59(6):1190-3. PubMed ID: 17434881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. False synergy between vancomycin and beta-lactams against glycopeptide-intermediate Staphylococcus aureus (GISA) caused by inappropriate testing methods.
    Goldstein FW; Atoui R; Ben Ali A; Nguyen JC; Ly A; Kitzis MD
    Clin Microbiol Infect; 2004 Apr; 10(4):342-5. PubMed ID: 15059127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The activity of daptomycin against wild-type Staphylococcus aureus and strains with reduced susceptibility to vancomycin.
    Sader HS; Jones RN
    Clin Infect Dis; 2006 Sep; 43(6):798-9; author reply 799-800. PubMed ID: 16912964
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of accessory gene regulator (agr) group and function in the proclivity towards vancomycin intermediate resistance in Staphylococcus aureus.
    Tsuji BT; Rybak MJ; Lau KL; Sakoulas G
    Antimicrob Agents Chemother; 2007 Mar; 51(3):1089-91. PubMed ID: 17158941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus.
    Tenover FC; Moellering RC
    Clin Infect Dis; 2007 May; 44(9):1208-15. PubMed ID: 17407040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Occurrence of a USA300 vancomycin-intermediate Staphylococcus aureus.
    Hageman JC; Patel J; Franklin P; Miscavish K; McDougal L; Lonsway D; Khan FN
    Diagn Microbiol Infect Dis; 2008 Dec; 62(4):440-2. PubMed ID: 18842378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression and detection of hetero-vancomycin resistance in Staphylococcus aureus.
    Howe RA; Wootton M; Walsh TR; Bennett PM; MacGowan AP
    J Antimicrob Chemother; 1999 Nov; 44(5):675-8. PubMed ID: 10552985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Investigation of glycopeptide resistance in methicillin resistant staphylococcal isolates].
    Hoşgör Limoncu M; Ermertcan S; Taşli H; Kurutepe S
    Mikrobiyol Bul; 2007 Oct; 41(4):511-6. PubMed ID: 18173069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vancomycin-intermediate Staphylococcus aureus in a home health-care patient.
    Hageman JC; Pegues DA; Jepson C; Bell RL; Guinan M; Ward KW; Cohen MD; Hindler JA; Tenover FC; McAllister SK; Kellum ME; Fridkin SK
    Emerg Infect Dis; 2001; 7(6):1023-5. PubMed ID: 11747733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Daptomycin nonsusceptibility in Staphylococcus aureus with reduced vancomycin susceptibility is independent of alterations in MprF.
    Pillai SK; Gold HS; Sakoulas G; Wennersten C; Moellering RC; Eliopoulos GM
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2223-5. PubMed ID: 17404001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05.
    Steinkraus G; White R; Friedrich L
    J Antimicrob Chemother; 2007 Oct; 60(4):788-94. PubMed ID: 17623693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Septic arthritis caused by vancomycin-intermediate Staphylococcus aureus.
    Lu JJ; Lee SY; Hwa SY; Yang AH
    J Clin Microbiol; 2005 Aug; 43(8):4156-8. PubMed ID: 16081964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA).
    Appelbaum PC
    Int J Antimicrob Agents; 2007 Nov; 30(5):398-408. PubMed ID: 17888634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Heteroresistance in Vancomycin-Intermediate Staphylococcus aureus (VISA), susceptible or resistant?].
    Labarca J
    Rev Chilena Infectol; 2015 Oct; 32(5):497-8. PubMed ID: 26633104
    [No Abstract]   [Full Text] [Related]  

  • 38. Telavancin and vancomycin pharmacodynamics with Staphylococcus aureus in an in vitro dynamic model.
    Lubenko IY; Strukova EV; Smirnova MV; Vostrov SN; Portnoy YA; Zinner SH; Firsov AA
    J Antimicrob Chemother; 2008 Nov; 62(5):1065-9. PubMed ID: 18635520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erroneous reporting of vancomycin susceptibility for Staphylococcus spp. by Vitek software version 2.01.
    Behera B; Mathur P
    Jpn J Infect Dis; 2009 Jul; 62(4):298-9. PubMed ID: 19628909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacodynamics of dalbavancin studied in an in vitro pharmacokinetic system.
    Bowker KE; Noel AR; MacGowan AP
    J Antimicrob Chemother; 2006 Oct; 58(4):802-5. PubMed ID: 16891629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.